MD Candidate (Baylor College of Medicine, Class of 2026) with a BS in Neuroscience (UT Austin). Passionate about general surgery, surgical oncology research, and leadership in medicine.
· Zielinski R, Zal T, Grela K, Skora S, Fokt I, Sander M, Remiszewski M, Felix E, Shanmugasundaram M, Priebe W. Dose and schedule-dependent efficacy of liposomal Annamycin in pre-clinical models of acute myeloid leukemia. Poster presented at: AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference; 2019 Oct 26-30; Boston, MA.
· Zielinski R, Grela K, Skora S, Fokt I, Sander M, Didluch A, Priebe W. Liposomal Annamycin Inhibition of Lung Localized Breast Cancer. Poster presented at: 42nd Annual San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX.
· Zielinski R, Grela K, Skora S, Jacamo R, Fokt I, Sander M, Remiszewski M, Felix E, Shanmugasundaram M, Zal MA, Andreeff M. Biodistribution and Efficacy of L-Annamycin in a Novel Imageable AML Mouse Model. Blood. 2019;134(Supplement_1):5150.
· Sander M, Kotta PA. MRSA: An Uncommon Cause of UTI. Society of Hospital Medicine Houston Chapter Virtual Conference 2023.
· Pena AL, Salan-Gomez M, Sander M, Fernandez R, Garcha P, Mattar A, Elsenousi A, Shafii A, Loor G. Baseline Lung Allograft Dysfunction: Clinical Characteristics, Outcomes, and Contributing Factors. Journal of Heart and Lung Transplantation. 2024 Apr 1;43(4):S445-6.
· Engebretson H, Blackburn K, Sander M, Anbarasu C, Hsu C, Silberfein EJ, Awad S, Choi E, Chai C, Camp ER, Van Buren G, Fisher W, Erstad DJ. Impact of Obesity on Pancreaticoduodenectomy Perioperative Outcomes. Annals of Surgical Oncology. (2025 Manuscript Submitted).
· Guinn T, Miles T, Hills E, Sander M, Nguyen A, Fernandez R, Loor G, Ghanta R, Rana A. A Novel Chronic Lung Allograft Dysfunction (CLAD) Risk Score. Academic Surgical Congress 2026. (Abstract Submitted).
· Sander M, Manisundaram N, Camp ER, Erstad DJ. Taking Advantage of the Chemotherapeutically Altered Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma. (Manuscript in preparation, anticipated submission September 2025).
· Sander M, Nack T, Erstad DJ. Upfront Locoregional Therapy Prior to Resection for Hepatocellular Carcinoma Fails to Improve Survival and Recurrence Outcomes: A Single Center Experience. South Texas Chapter ACS Annual Meeting 2026. (Abstract pending submission September 2025).